University of Oxford

Oxford Vacmedix team support new University of Oxford educational initiative

The team at Oxford Vacmedix contribute to the design and the delivery of a novel MSc course in Applied Cancer Science being run by the Department of Oncology at the University of Oxford Oxford, UK – 26th February 2024 Press Release – Oxford Vacmedix support new University of Oxford educational initiative Oxford Vacmedix (OVM), the clinical stage company developing therapeutic cancer vaccines, announced today the involvement of the Management team in a brand new MSc course being run i...
Read More

Oxford Vacmedix sponsors MRC i-Case studentship at University of Oxford

New appointment In Professor Shisong Jiang’s research group in the Department of Oncology brings further expertise to research applications for Recombinant Overlapping Peptides (ROPs) Oxford, UK – 5th April 2023 Press Release – Oxford Vacmedix sponsors MRC i-Case studentship at University of Oxford Oxford Vacmedix (OVM), the UK-based biopharma company focused on the development of therapeutic cancer vaccines, announced today the award of an MRC i-Case studentship to fund a new D.Ph...
Read More
en_GBEnglish